Simergent Develop Affordable Home Dialysis Device For Emerging Markets

Simergent Develop Affordable Home Dialysis Device For Emerging Markets

Over 2 million people worldwide receive treatment with dialysis to stay alive, yet this number may only represent 10% of people who actually need treatment. Every year, over 2.3 million people die around the world because they can’t afford or access dialysis. Of the people who receive treatment, a majority is treated in only five countries: the US, Japan, Germany, Brazil and Italy. In middle-income countries, dialysis creates a huge financial burden for the majority of people who need it, and it is estimated that the number of cases of kidney failure will increase disproportionately in developing countries.

The Chicago-based startup Simergent is developing an affordable home dialysis device that automatically administer peritoneal dialysis therapy to patients at night while they sleep. Unlike the more commonly used treatment option hemodialysis, patients do not have to travel to a hospital or dialysis center multiple times per week, and there is no blood removal or needles involved. The startup’s technology consists of an electromechanical device, a disposable tubing set, and proprietary software that manages fluid delivery. Through simple easy-to-follow directions via a touch screen, the system pumps dialysis solution through the sterile disposable tubing into a surgically implanted port in the patient’s abdomen. The filtered out waste products is cycled out of the body and discarded.

The prevalence of kidney disease is increasing dramatically and access to dialysis remains limited in several regions of the world due to lack of financial and clinical resources. Treatment require expensive equipment and materials, as well as personnel, making kidney disease a death sentence for many people. Simergent is developing a paradigm-changing home dialysis system, and is specifically targeting emerging markets including India and China. The device cost less than 70% of traditional devices and give easy-to-follow instruction, enabling patients to do the procedure themselves at home. In addition, the system generates sterile dialysis solutions within the patients’ homes, eliminating the need to store large boxes of solution within their own home. The technology address specific needs for emerging markets with its low-cost, low-literacy and rural friendly design. It eliminates the infrastructural requirements of clinics, transportation and trained staff, allowing patients to live normal lives while receiving quality care. The drastic reduction in cost opens the door to treatment for millions of new patients, meaning kidney disease no longer have to be a death sentence no matter where you live in the world.

Simergent was founded by Steve Lindo and Rick Pendergraft and spun out of SIM Solutions in April 2016. The startup is a member of the MATTER startup incubator community, and has previously been selected as a finalist in the Propel business plan competition, the eMERGE Americas Startup Showcase, and was in 2017 chosen as one of the Medtech Innovator Top 100 companies.